Columbia scientists are using CRISPR to create stem cells that could ultimately alleviate diabetes in rare neonatal cases and may lead to a cell therapy for more common forms of the disease.
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.
Study of insulin-producing cells derived from skin of diabetes patients shows utility of iPS cells for study of human disease and as potential therapy.
Obese adolescents are more likely than their normal-weight counterparts to have hearing loss – results of a new study led by Columbia’s Dr. Anil Lalwani.
A Mailman School of Public Health study finds that low-income individuals would not be disproportionately affected by legislation to restrict consumption of large sugar-sweetened beverages.
Type 1 diabetes appears to increase the risk of heart disease, the leading cause of death among people with high blood sugar, partly by stimulating production of a protein that sparks an inflammatory process.